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Available online 18 November 2005Abstract—A synthetic approach towards the novel anti-inflammatory diterpenoid rameswaralide from the cis-Corey lactone involv-
ing a tandem RCM and Diels–Alder reaction has been conceived and endeavors so far have led to the acquisition of the BCD ring
fragment of the natural product.
 2005 Elsevier Ltd. All rights reserved.O
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10In 1998, collaborative efforts between the research
groups of Venkateswarlu and Faulkner led to the isola-
tion of a novel diterpenoid, rameswaralide 1, from the
soft coral Sinularia dissecta collected from the Manda-
pam coast two years earlier.1 The stereostructure of 1
was determined through recourse to incisive 2D NMR
techniques and chemical transformation to dihydro-
rameswaralide 2 to reveal the presence of the unusually
stable enol moiety.1 The unique framework of rames-
waralide 1 has close biosynthetic kinship with the diter-
penoids mandapamate 3 and isomandapamate 4 with
which it co-occurs in the same soft coral species.2 The
tetracyclic framework of rameswaralide 1, composed
of a 5,7,6-fused tricarbocyclic core and functionalities
spread in all its rings and embellished with six stereo-
genic centres is a challenging synthetic target in its
own right. However, it is the observation of promising
anti-inflammatory activity3 associated with 1 and its
derivatives, with inhibitory activity against TNF-a, IL-
15, IL-5 and Cox2 with an IC50 in 0.5–5 lg/mL concen-
tration3 that has added special attraction to its synthetic
pursuit. Although a total synthesis of 1 has not been
achieved so far, a related model study4 has recently sur-
faced in the literature. As part of our continuing interest
in the total synthesis of diterpenoids with 5,7,6-fused
tricarbocyclic frameworks,5 we disclose in this letter a
synthetic approach to 1 that has so far culminated in
the acquisition of the BCD tricyclic core present in the
natural product.0040-4039/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2005.11.017
* Corresponding author. Tel.: +91 80 22932850; fax: +91 80
23600283; e-mail: gm@orgchem.iisc.ernet.inOur synthetic strategy towards 1 evolved around the
retrosynthetic theme is depicted in Scheme 1. It was
envisaged that the cis-fused six-membered ring A could
be appended to the preformed tricyclic BCD core 5
through [4+2]-cycloaddition protocols on the enone
moiety. Thermal and Lewis acid catalyzed Diels–Alder
reactions to cycloheptenones are well precedented6 and
in the case of 5 an examination of models revealed that
the cycloaddition was expected to be face selective with
the diene approaching from the a-face to deliver the
desired C5,C14 ring junction stereochemistry. The key
cycloheptenone moiety in 5 was sought to be generated
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Scheme 1. Retrosynthetic strategy.
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Scheme 2. Reagents and conditions: (a) CH3OCH2PPh3Cl, KO
tAm,
THF, 0 C, 2 h, 80%; (b) HClO4 (cat.), DCM, 0 C, 2 h, 93%; (c)
NaBH4, MeOH, 0 C, 1 h, quant., 11:12 = 4:1; (d) (i) TBSCl,
imidazole, DCM, rt, 1 h, 96%; (ii) K2CO3, MeOH, 10 h, 92%; (c)
TPAP, NMMO, rt, DCM, 3 h, 94%.
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Scheme 3. Reagents and conditions: (a) mCPBA, NaHCO3/PTSA,
0 C to rt, 2 h, 89%; (b) H2O2, NaOH, MeOH, 0 C, 2 h, 95%; (c)
CF3COOOH, KH2PO4, DCM, 0 C, 1 h, 95%; (d) (i) NaOH, MeOH,
rt, 12 h; (ii) KI, I2, H2O, rt, 3 h, 86% (two steps); (e) TESCl, Py, rt,
12 h, 90%; (f) (nBu)3SnH, AIBN, C6H6, D, 2 h, 95%.
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elaborated from the all cis-Corey lactone 77 (Scheme
1). The choice of the all cis-Corey lactone 7 as the launch
pad was crucial as it embodies the CD rings of the nat-
ural product 1 and the required stereochemistry at C7,
C10 and C11 is embedded into it. Therefore, our initial
objective was to devise a convenient access to 7 in an
appropriately protected form for further elaboration.
Several syntheses of the all cis-Corey lactone, emanating
from diverse starting materials, have been recorded in
the literature, particularly in the context of accessing iso-
prostanes and related prostaglandin analogues.7 How-
ever, our present endeavors warranted development of
a de novo synthesis of 7 and that became our initial
objective. Towards this end, the recently reported8 and
readily available 7-keto-norbornene derivative 8 was
selected as the starting material. Wittig methoxymethyl-
enation in 8 led to enol ether 9 and carefully controlled
acid catalyzed hydrolysis (<0 C) in 9 to the intermedi-
ate aldehyde 10 followed by immediate borohydride
reduction led to a readily separable mixture (4:1) of
the syn-119 and anti-12 alcohols in good yield (Scheme
2). Protection of the hydroxyl group in 11 as its TBS
derivative followed by acetate hydrolysis and TPAP oxi-
dation furnished the syn-norbornenone derivative 13.9
Baeyer–Villiger oxidation of 13 presented some initial
chemoselectivity problems (Scheme 3) because of the
steric shielding of the C2 carbonyl group by the C7
syn substituent but high chemoselectivity was secured
by carrying out the reaction in basic H2O2 to obtain lac-
tone 15 with the complete exclusion of the epoxide prod-
uct 14. Reconstructive iodolactonization10 of 15 furnished
iodolactone 169 in good yield, however, we were
surprised to find that the TBS protection was lost during
the process (Scheme 3). The two hydroxyl groups in 16
were protected as the TES derivative 17 and reductive
deiodination furnished the all cis-Corey lactone deriva-
tive 18 (Scheme 3).9 Although the route to 18 was some-
what long, its execution was straightforward and this
key intermediate could be routinely obtained in gram
quantities.The next task was to set up the RCM reaction to gener-
ate the seven-membered B ring of rameswaralide 1. In
this context, lactone 18 was stereoselectively allylated
to yield 19 with the addition exclusively from the convex
face (Scheme 4).9 Selective deprotection of the primary
hydroxyl group in 19 led to 20 and further PDC oxida-
tion furnished the sensitive endo-aldehyde 21 (Scheme
4). Addition of vinylmagnesium bromide to 21 gave
the diastereomeric mixture 22 and was as such oxidized
with PDC to enone 239 required for effecting the key
RCM reaction. Exposure of 23 to the Grubbs second
generation catalyst11 resulted in smooth generation of
the desired cycloheptenone moiety and formation of
24.9 The stereostructure of 24 was secured through an
X-ray crystal structure determination.12
With the availability of the advanced BCD ring interme-
diate 24, its Diels–Alder reactions with several dienes
(1,3-butadiene, isoprene, furan, etc.) were attempted to
append the A ring for which the literature precedent
Scheme 4. Reagents and conditions: (a) LHMDS, HMPA, 78 C, 15 min, allyl bromide, 78 C, 1.5 h, 89%; (b) PPTS, MeOH, 0 C, 4 h, 95%; (c)
PDC, DCM, 0 C, 3 h, 82% (no column chromatography); (d) H2C@CHMgBr, THF, 78 C, 30 min, 80%; (e) PDC, DCM, 0 C, 4 h, 85%; (f)
Grubbs II gen. catalyst (10 mol %), DCM, rt, 5 h, 90%.
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Scheme 5. Enyne metathesis—Diels–Alder strategy.
O
OR
OR
O
O
OR
CHO
O
O
ORO
OH
O
ORO
O
H
H
H
H
H
H
H
H
18
O
O
H
H
O
OR
32 R = TES
28 29
3031
a b
c
d
X
e
Scheme 6. Reagents and conditions: (a) LHMDS, HMPA, 78 C,
15 min, propargyl bromide, 78 C, 1.5 h, 91%; (b) (i) PPTS, MeOH,
0 C, 3 h, quant.; (ii) PDC, DCM, 0 C, 3 h, 88% (no column
chromatography); (c) H2C@CHMgBr, THF, 78 C, 30 min, 64%;
(d) PDC, DCM, 0 C, 4 h, 80%; (e) Grubbs I/II gen. catalyst, DCM/
benzene/toluene, rt/reflux.
G. Mehta, S. Lakshminath / Tetrahedron Letters 47 (2006) 327–330 329exists.6 However, despite several such attempts under
different thermal and catalyzed regimes, success eluded
us and this forced us to explore an alternative approach
although not successfully. The alternative procedure
that we sought to append ring A was through an enyne
metathesis13 in a precursor such as 25 to furnish the
diene 26 which was expected to be more amenable to
Diels–Alder reaction to deliver ring A as in 27 (Scheme
5).
Consequently, the TES protected cis-Corey lactone 18
was propargylated to give 28 (Scheme 6).9 Selective
deprotection of the primary hydroxyl group and PDC
oxidation led to aldehyde 29.9 Addition of vinylmagne-
sium bromide to 29 furnished vinyl alcohols 30, which
were further oxidized to enone 31 to set up the enyne
metathesis. Exposure of 31 to Grubbs first or second
generation catalyst, to our great disappointment, failed
to deliver the expected product 32. This called for fur-
ther tactical adjustments to facilitate the enyne meta-
thesis and efforts along these lines are being pursued.
In summary, we have delineated a synthetic approach
towards the novel anti-inflammatory diterpene rames-
waralide in which cis-Corey lactone serves as an advanced
building block with a tandem RCM reaction and [4+2]-
cycloaddition as key steps. In this context, a new synthe-
sis of cis-Corey lactone has been devised and it has been
further elaborated to the BCD ring core structure of the
natural product rameswaralide.Acknowledgements
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